| Financial Year |
March 31 2023 |
| Monetary Funds |
11,427,709,857.04 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
11,175,866,308.37 |
| Accounts Receivable |
6,586,622,642.14 |
| Advances to Suppliers |
2,571,410,401.34 |
| Other Receivables |
1,561,962,012.13 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
22,740,658.76 |
| Dividend Receivable |
14,449,746.16 |
| Inventories |
17,173,381,830.51 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
27,900.00 |
| Other Current Assets |
474,310,794.93 |
| Total Current Assets |
54,950,786,126.59 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
20,000,000.00 |
| Long-term Equity Investment |
650,235,660.94 |
| Investment Properties |
98,193,060.54 |
| Fixed Assetes |
48,723,825,871.41 |
| Under-construction Projects |
6,241,379,087.18 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
7,347,842,805.06 |
| R&D expenses |
-- |
| Goodwill |
18,331,368.65 |
| Long-Term Deferred and Prepaid Expenses |
183,791,198.70 |
| Deferred Income Tax Assets |
1,905,392,717.37 |
| Other Non-Current Assets |
818,095,995.10 |
| Sub-Total of Non-Current Assets |
66,038,065,207.18 |
| Total Assets |
120,988,851,333.77 |
| Short-Term Loans |
11,297,620,380.56 |
| Trading Financial liabilities |
-- |
| Notes Payable |
6,605,904,163.12 |
| Accounts Payable |
17,845,536,231.37 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
1,874,321,190.46 |
| Taxes Payable |
770,241,464.94 |
| Interest Payable |
34,300,512.88 |
| Dividend Payable |
12,862,468.07 |
| Other payables |
6,383,631,326.87 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
3,119,540,771.87 |
| Other Current Liabilities |
512,848,083.88 |
| Sub-Total of Current Liabilities |
52,354,628,873.72 |
| Long-term Loans |
17,637,156,880.44 |
| Bonds Payable |
4,650,083,454.43 |
| Long-Term Accounts Payable |
2,900,000,000.00 |
| Special Payable |
-- |
| Estimatied Liabilities |
34,244,347.91 |
| Deferred Income Tax Liabilities |
760,963,434.54 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
27,469,658,127.75 |
| Total Liabilities |
79,824,287,001.47 |
| Paid-In Capital(Or Share Stock) |
5,047,155,266.00 |
| Capital Surplus |
9,376,162,822.13 |
| Surplus Reserve |
1,655,984,973.68 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
21,121,030,204.04 |
| Minority Stockholder's Interest |
3,207,714,474.62 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
37,956,849,857.68 |
| Owner's Equity（Stockholder's Equity） |
41,164,564,332.30 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
120,988,851,333.77 |
